GT Kannarkat, JM Boss… - Journal of Parkinson's …, 2013 - content.iospress.com
In recent years, inflammation has become implicated as a major pathogenic factor in the onset and progression of Parkinson's disease. Understanding the precise role for …
Parkinson's disease (PD) is one of the most common neurodegenerative diseases. It is characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta of …
V Sanchez-Guajardo, CJ Barnum, MG Tansey… - ASN …, 2013 - journals.sagepub.com
The role of neuroinflammation and the adaptive immune system in PD (Parkinson's disease) has been the subject of intense investigation in recent years, both in animal models of …
D Béraud, HA Hathaway, J Trecki… - Journal of Neuroimmune …, 2013 - Springer
Parkinson's disease (PD) is the second most common age-related neurodegenerative disorder typified by tremor, rigidity, akinesia and postural instability due in part to the loss of …
M Deleidi, T Gasser - Cellular and Molecular Life Sciences, 2013 - Springer
The etiology of Parkinson's disease (PD) is complex and most likely involves numerous environmental and heritable risk factors. Interestingly, many genetic variants, which have …
V Sanchez-Guajardo, A Annibali… - … of Neuropathology & …, 2013 - academic.oup.com
Human leukocyte antigen-DR induction and lymphocyte infiltrates in the brains of patients with Parkinson disease (PD) and the presence in serum of α-synuclein (α-syn)-specific …
AR Carta - Current drug targets, 2013 - ingentaconnect.com
Parkinson's disease (PD) is amongst the most frequent neurodegenerative disorders, the main pathologic hallmark of which is the degeneration of the substantia nigra pars …
Abstract α-Synuclein (AS)-positive inclusions are the pathological hallmark of Parkinson's disease (PD), dementia with Lewy bodies (DLB) and multiple system atrophy (MSA), all …
S Pradhan, K Andreasson - Experimental neurology, 2013 - Elsevier
Parkinson's disease (PD) is a progressive neurodegenerative disorder with three cardinal features of pathology: 1. Aggregation of α-synuclein into intraneuronal structures called …